Integra LifeSciences (IART) Tops Q4 EPS by 3c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Above Consensus, FY19 Revenue Views Below Estimates
Go back to Integra LifeSciences (IART) Tops Q4 EPS by 3c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Above Consensus, FY19 Revenue Views Below Estimates| Integra LifeSciences Holdings (NASDAQ: IART) | Delayed: 18.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.34 | 52 Week High | $88.86 | |||
| Open | $18.34 | 52 Week Low | $54.75 | |||
| Day High | $18.34 | P/E | N/A | |||
| Day Low | $18.34 | EPS | $-0.59 | |||
| Volume | 210 | |||||

